Celsion Corp (CLSN) Stock

DelistedNasdaq: CLSNCelsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies.

1.45
Final close · Nov 22, 2022

CLSN is no longer traded. Celsion was delisted from the Nasdaq in November 2022.

Prices on this page are historical; the last trade was November 22, 2022 at $1.45.

Celsion stock price history

Split-adjusted closes, 1985–2022

CLSN final trading statistics

Final close
$1.45
Final trading day
Nov 22, 2022
Market cap at delisting
$10.29M
Shares outstanding
7.10M
Final 52-week range
$0.31 – $7.68
Avg. volume (final 3 mo.)
43,446
All-time high (split-adj.)
$9810.99 · Mar 2000
All-time low (split-adj.)
$1.43 · Nov 2022
Return since IPO
-99.7%
Beta
2.26
Book value / share
$6.63
Price / book
0.22
Final 52 wk
0.317.68

Celsion earnings per share

Earnings per share

Celsion revenue & net income

RevenueNet income

Celsion annual financials

Celsion Corp revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2021$500.0K-$20.8M-$6.77
FY2020$500.0K-$21.5M-$10.05
FY2019$500.0K-$16.9M-$2.16
FY2018$500.0K-$11.9M-$1.25
FY2017$500.0K-$20.4M-$3.48

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Celsion Corp

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

Celsion stock FAQ

What happened to Celsion stock?

Celsion stock was delisted from the Nasdaq. Its final close was $1.45 on November 22, 2022.

Is CLSN stock still trading?

No. CLSN was delisted from the Nasdaq in November 2022 and no longer trades on a U.S. exchange.

What was the last price of CLSN stock?

CLSN closed at $1.45 on its final trading day, November 22, 2022, for a market value of about $10.29M.

What were Celsion's revenue and earnings in its last full fiscal year?

Celsion reported revenue of $500.0K and net income of -$20.8M in fiscal 2021, its last full year as a public company.

When did Celsion go public?

Celsion Corp stock began trading on March 5, 1985.

Biotechnology & Medical Research stocks to research

All Healthcare stocks →